Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2009

View Archived Issues

GSK claims calcium receptor antagonists for the treatment of bone and bone mineral disorders

sCD83 shows promising preclinical potential for the treatment of transplant rejection

Intramuscular laminin-111 delivery prevents degeneration in DMD mouse model

New guanylate cyclase activators under development at GSK for the treatment of hypertension

Schering-Plough discloses CDK2 and Chk1 inhibitors for cancer treatment

Galapagos initiates first-in-human phase I clinical trial of GLPG-0187 in bone metastasis

Cenix and AstraZeneca sign agreement in respiratory and inflammation-related indications

Advaxis reports survival data from phase I trial of live Listeria vaccine ADXS-11-001

Javelin reports results from phase I study of Dyloject in renal and hepatic impairment

Prospect Therapeutics reports results from in vitro studies of GCS-100 in cancer

ARYx Therapeutics provides update on tecarfarin EmbraceAC study

FDA extends review of BLA application for Arzerra

Almirall presents beta2-adrenoceptor agonists for the treatment of asthma

Taisho discovers histamine H3 receptor inhibitors for the treatment of Alzheimer's disease

ASCO snapshots: phase I/II data on novel treatments for metastatic breast cancer disclosed

Gastric pentadecapeptide BPC-157 shows beneficial cytoprotective effects in various rat models

Medicis launches Dysport in the U.S. for the treatment of glabellar lines

SIGA completes nonclinical toxicology studies in support of NDA for ST-246

Schering-Plough extends antibody alliance with MorphoSys until 2010

Pluristem receives European regulatory approval for placental-derived stem cell trial

FibroGen starts enrollment in phase II FG-3019 study in diabetic kidney disease

Bioalliance Pharma submits NDA to FDA for Loramyc

PhytoMedical presents update on its anticancer compound research and development

FDA committee recommends granting of marketing approval to Savient's Krystexxa for gout

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...